Genomcore wins European PRECISEU Award
Genomcore has just won the PRECISEU Best Practice Recognition in the Impact category for its management of biomedical data in the DIPCAN project.
Genomcore's pioneering innovation, conceived in Spain, has not merely proven its readiness for the European stage; it is rapidly establishing itself as the undisputed benchmark across the continent's personalised medicine ecosystem.
The company solidifies its position on the European map of precision medicine and the use of biomedical data with the Genomcore BIMS platform and its involvement in the DIPCAN project.
Genomcore has just won the PRECISEU Best Practice Recognition in the Impact category for its management of biomedical data in the DIPCAN project. DIPCAN harmonised over 60TB of data from 130 Spanish hospitals, generated reports for more than 2,000 patients, and trained AI models for a more efficient and personalised diagnosis.
The European project PRECISEU (PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope) includes more than 12 European regions from 10 Member States (Spain, Germany, Belgium, Bulgaria, Romania, Italy, Lithuania, Sweden, Netherlands, and Greece), along with Ukraine, a country associated with the Horizon Europe programme.
The goal of the PRECISEU Awards is to accelerate the future of personalised medicine across Europe by highlighting and promoting the pioneers who are transforming cutting-edge science into real healthcare, particularly through the innovative and responsible use of health data.
